Latest News in the pharma Industry
Research & Development
Maverick: an emergency auto-injector designed for total patient safety
16 Sep 2020
The Maverick emergency auto-injector merges Duoject Medical System’s design and development expertise with Stevanato Group’s contract manufacturing capabilities. Six Human Factor studies conducted over 150 patients show how the current conf...
Read more
Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate
15 Sep 2020
Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19.
Read more
Evotec and Bioaster partner to build technology and innovation hub in Lyon
14 Sep 2020
Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies.
Read more
Exelixis and Catalent collaborate to develop antibody-drug conjugates
8 Sep 2020
The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
Read more
Key trends boosting the post-pandemic CRO market
8 Sep 2020
Hybrid clinical trials leveraging safety-focused, direct-to-consumer logistical solutions are taking center stage, ensuring research continuity.
Read more
INOVIO signs up Thermo Fisher to support COVID-19 vaccine production
8 Sep 2020
The CDMO will support INOVIO's plans to have 100 million doses of COVID-19 vaccine candidate INO-4800 manufactured in 2021.
Read more
AstraZeneca's COVID-19 vaccine candidate enters Phase III trials in the US
2 Sep 2020
Trial enrolling up to 30,000 adults aged 18 years or over to assess safety, efficacy and immunogenicity of AZD1222 for the prevention of COVID-19.
Read more
New syringe technology could make the 'uninjectable' injectable
25 Aug 2020
Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.
Read more
BMS adds lead TGF-beta asset to portfolio through acquisition
25 Aug 2020
Forbius's lead investigational asset, AVID200 holds promise as an effective and well-tolerated therapeutic in fibrotic diseases and immuno-oncology.
Read more.jpg)
Catalent expands manufacturing support for COVID-19 vaccine AZD1222
24 Aug 2020
The company will prepare the Harmans facility to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing later this year.
Read more.png)
CRO Europital opens new UK site in response to urgent demand
24 Aug 2020
The company will target working with small and medium biotechs who require a science-driven, rather than a volume-driven partner.
Read more
J&J agrees in principle to supply UK with its COVID-19 vaccine candidate
18 Aug 2020
Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators.
Read more